Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
All Genders
Healthy Volunteers
NCT04087655

Microvascular Dysfunction in Obesity

Led by Florida State University · Updated on 2025-12-11

25

Participants Needed

1

Research Sites

392 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Impaired endothelial function is observed in disease states related to obesity, such as atherosclerosis, coronary artery disease, and diabetes. Reactive oxygen species (ROS) production and resultant oxidative stress contribute to the development of these obesity-related diseases. The enzyme NADPH-oxidase is a major source of oxidative stress within the vasculature, and has been linked with the Metabolic Syndrome. In the investigator's previously funded studies, the investigators demonstrated for the first time that: 1) in vivo ROS were elevated in skeletal muscle of obese as compared to lean or overweight human subjects, 2) perfusion of the NADPH-oxidase inhibitor apocynin locally into muscle normalized ROS levels and reversed local microvascular endothelial dysfunction in the obese individuals, and 3) aerobic exercise training was effective at attenuating in vivo hydrogen peroxide production and reversing microvascular endothelial dysfunction in the obese individuals. The investigators will investigate in this R15 renewal application the mechanism of exercise training-induced alterations in ROS production and action on endothelial dysfunction in obesity using our newly developed microdialysis methodology of monitoring ROS production, in combination with analysis of muscle biopsy samples obtained before and after our previously tested 8-week intervention of aerobic interval exercise training. The objectives of this study are to determine the impact of in vivo NADPH oxidase activity on endothelial function in obese individuals, and to determine the mechanism of training-induced improvements in endothelial function. The investigator's unique microdialysis methodology will allow monitoring of microvascular/endothelial function and ROS generation, as well as the administration of pharmacological agents directly into muscle. The central hypothesis is that it is upregulation of both mitochondrial ROS and NADPH oxidase-derived ROS that results in endothelial dysfunction in obesity, and that exercise training down-regulates mitochondrial-derived ROS, and NADPH oxidase 4, thereby improving endothelial function. The aims of this proposal are to: 1) determine the contributions of mitochondrial ROS and specific NADPH oxidase isoforms to the NADPH oxidase dependent endothelial dysfunction in skeletal muscle of obese individuals; 2) determine the mechanism of ROS reduction and improved endothelial function resulting from an 8-week aerobic interval training program.

CONDITIONS

Official Title

Microvascular Dysfunction in Obesity

Who Can Participate

Age: 18Years - 45Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • No restrictions on race, sex, or socioeconomic status
  • Premenopausal women on combined estrogen/progestin hormonal contraceptive therapy
  • Sedentary obese individuals who have been weight stable for 6 months
  • Adults aged 18 to 45 years
  • Diagnosis of Metabolic Syndrome with at least three of the following:
    1. Waist circumference over 40 inches (men) or over 35 inches (women)
    2. Fasting triglycerides over 150 mg/dL
    3. HDL cholesterol under 40 mg/dL (men) or under 50 mg/dL (women)
    4. Blood pressure over 130/85 mmHg
    5. Fasting blood glucose over 110 mg/dL or 2-hour glucose tolerance test between 140-200 mg/dL
Not Eligible

You will not qualify if you...

  • Participation in endurance exercise training more than 20 minutes per day or more than once per week
  • Pregnant or lactating women
  • Irregular menstrual cycles in premenopausal women
  • Use of medications affecting circulation
  • Use of nonsteroidal anti-inflammatory drugs or serotonin reuptake inhibitors
  • Current tobacco use (smoking or chewing)
  • Diabetes with fasting blood glucose over 125 mg/dL
  • Hypertension over 160/95 mmHg
  • Congestive heart failure, angina, or peripheral vascular disease
  • Serious arrhythmias or acute myocardial ischemia
  • Chronic infections, paralysis from stroke, advanced Parkinson's disease, severe rheumatoid arthritis, or serious orthopedic problems preventing exercise
  • Use of antioxidant, herbal, or vitamin supplements within 2 weeks before study
  • Consumption of caffeine on the day of testing
  • Weight change over 5% during training
  • Exercise adherence below 90% of sessions or total exercise time

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Florida State University

Tallahassee, Florida, United States, 32306

Actively Recruiting

Loading map...

Research Team

R

Robert C Hickner, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here